Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rottoli

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Respiratory Medicine|March 30, 2019
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?F Bianchi, C Piccioli, E Rosi, et al.
Journal of Proteomics|September 7, 2015
A functional proteomics approach to the comprehension of sarcoidosisC Landi, E Bargagli, A Carleo, et al.
Journal of Breath Research|April 16, 2016
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosisA Carleo, E Bargagli, C Landi, et al.
Journal of Biological Regulators and Homeostatic Agents|September 27, 2005
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patientsG D Sebastiani, F Bellisai, C Caudai, et al.
Arzneimittel-Forschung|January 1, 1982
A multicentre controlled trial of terfenadine, dexchlorpheniramine, and placebo in allergic rhinitisG Melillo, G D'Amato, C Zanussi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Respiratory Medicine|March 30, 2019
Combined sarcoidosis and idiopathic pulmonary fibrosis (CSIPF): A novel disease phenotype?F Bianchi, C Piccioli, E Rosi, et al.
Journal of Proteomics|September 7, 2015
A functional proteomics approach to the comprehension of sarcoidosisC Landi, E Bargagli, A Carleo, et al.
Journal of Breath Research|April 16, 2016
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosisA Carleo, E Bargagli, C Landi, et al.
Journal of Biological Regulators and Homeostatic Agents|September 27, 2005
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patientsG D Sebastiani, F Bellisai, C Caudai, et al.
Arzneimittel-Forschung|January 1, 1982
A multicentre controlled trial of terfenadine, dexchlorpheniramine, and placebo in allergic rhinitisG Melillo, G D'Amato, C Zanussi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pageof 8